3833146 Group II gliosarcoma without therapy 2 3833153 Group II general population without comorbidities 1 3833143 Group II GERD patients without LPR symptoms 1 3833147 Group II glomerulonephritis 1 3833148 Group II group consisting of placebo 1 3833149 Group II group failing NOM 1 3833144 Group II group for insulin treatment 1 3833150 Group II Group I, sub-chronic lead ingestion 1 3833151 Group II Group I. Forty-five patients 1 3833152 Group II Group IV and positive control 1 3833145 Group II group of medium severity 1 3833163 Group II group of virus-infected chickens 1 3833159 Group II group patients underwent conservative treatment 1 3833160 Group II group treated with ranitidine 1 3833161 Group II group who received endurance training 1 3833162 Group II group with conventional analgesics 1 3833155 Group II group with high fat diet 1 3833156 Group II group with midthoracic fusion 1 3833157 Group II group with no additional application 1 3833158 Group II group with selective thoracic fusion 1 3833154 Group II group with symptomatic brain metastases 1 3833167 Group II group without diagnosed histological chorioamnionitis 1 3833168 Group II group without skin markings 1 3833164 Group II groups included intravesical mitomycin-C 1 3833165 Group II groups: Scaling and root planing 1 3833166 Group II ultrasound-guided TAP block with ropivacaine 1